Can we eliminate placebo in ALS clinical trials?

Author Department

Medicine

Document Type

Article, Peer-reviewed

Publication Date

4-1-2003

Abstract

BACKGROUND: Previous studies concluded that the decline in strength in patients with amyotrophic lateral sclerosis (ALS) is a linear function. If so, a patient's natural history might serve as the control, instead of placebo, in a clinical trial. METHODS:

Publication ISSN

0028-3878

Share

COinS